Financial Instruments and Fair Value Measurements (Schedules of Concentration of Risk) (Details)	3 Months Ended
	Mar. 28, 2025	Mar. 29, 2024
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | Amerisource Bergen Corporation [Member]
Concentration Risk
Concentration Risk, Percentage	21.20%	15.00%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage	27.10%	20.10%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]
Concentration Risk
Concentration Risk, Percentage	39.10%	34.90%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]
Concentration Risk
Concentration Risk, Percentage	17.20%	19.80%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage	11.30%	12.10%
Product Concentration Risk | Net Sales Attributable to Products | Acthar
Concentration Risk
Concentration Risk, Percentage	27.50%	22.00%
Product Concentration Risk | Net Sales Attributable to Products | Inomax
Concentration Risk
Concentration Risk, Percentage	14.90%	15.00%
Product Concentration Risk | Net Sales Attributable to Products | Therakos [Member]
Concentration Risk
Concentration Risk, Percentage		12.40%
Product Concentration Risk | Net Sales Attributable to Products | APAP
Concentration Risk
Concentration Risk, Percentage		11.00%